Vaccinations for older adults

Clinical Geriatrics

Volumn 16, Issue 9, 2008, Pages 38-46

  Bader, Mazen S ^a   Hawboldt, John ^b,c  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b School of Pharmacy   (Greece)

^c School of Medicine   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; DIPHTHERIA TETANUS VACCINE; FAMCICLOVIR; HEPATITIS A HEPATITIS B VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; JAPANESE ENCEPHALITIS VACCINE; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; RABIES VACCINE; TRIPLE VACCINE; TYPHOID VACCINE; VALACICLOVIR; VARICELLA ZOSTER VACCINE; YELLOW FEVER VACCINE;

ABDOMINAL PAIN; ALLERGIC REACTION; ARTHRALGIA; COLLAPSE; COMMUNITY ACQUIRED PNEUMONIA; COST EFFECTIVENESS ANALYSIS; DIZZINESS; DRUG ADMINISTRATION; DRUG WITHDRAWAL; ELDERLY CARE; ENCEPHALITIS; ENCEPHALOMYELITIS; FEVER; GUILLAIN BARRE SYNDROME; HEADACHE; HERPES ZOSTER; HUMAN; HYPOTENSION; IMMUNE RESPONSE; IMMUNIZATION; INFLUENZA; INJECTION SITE PAIN; INJECTION SITE REACTION; MALAISE; MYALGIA; NAUSEA AND VOMITING; NEUROLOGIC DISEASE; QUALITY ADJUSTED LIFE YEAR; RASH; REVIEW; SINGLE DRUG DOSE; TRAVEL; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; URTICARIA; VACCINATION;

EID: 57749085552     PISSN: 10951598     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Castle SC, Uyemura K, Fulop T, Makinodan T. Host resistance and immune responses in advanced age. Clin Geriatr Med 2007;23(3):463-479, v.
2. Gorina Y, Hoyert D, Lentzner H, Goulding M. Trends in causes of death among older persons in the United States. U. S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Website. www.cdc.gov/nchs/data/ahcd/agingtrends/06olderpersons.pdf. Accessed July 22, 2008.
3. Fiore AE, Shay DK, Broder K, et al; Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC). Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recommn Rep 2008;57:1-60. Available at http://www.cdc.gov/mmwr/preview/mmwrhtml/rr57e717a1.htm.
4. Yawn BP, Saddier P, Wollan PC, St Sauver Jl, et al. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction [published correction appears in Mayo Clin Proc 2008;83(2):255]. Mayo Clin Proc 2007;82(11):1341-1349.
5. Helgason S, Petursson G, Gudmundsson S, Sigurdsson JA, et al. Prevalence of postherpetic neuralgia after a first episode of herpes zoster: Prospective study with long term follow up. BMJ 2000; 321:794-796.
6. Oxman MN, Levin MJ, Johnson GR, et al; Shingles Prevention Study Group. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005;352:2271-2284.
7. Rothberg MB, Virapongse A, Smith KJ. Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Clin Infect Dis 2007;44(10):1280-1288. Published Online: April 3, 2007.
8. Advisory Committee on Immunization Practices. Recommended adult immunization schedule: United States, October 2007-September 2008. MMWR 2007;56(41):Q1-Q4.
9. Harpaz R, Ortega-Sanchez IR, Seward JF; Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2008;57(RR-5):1-30, CE2-CE4.
10. Herpes zoster vaccine (Zostavax). Med Lett Drugs Ther 2006;48(1243):73-74.
11. Kimberlin DW, Whitley RJ. Varicella-zoster vaccine for the prevention of herpes zoster. N Engl J Med 2007;356:1338-1343.
12. Fernandez-Sabé N, Carratalà J., Rosón B, et al. Community-acquired pneumonia in very elderly patients: Causative organism, clinical characteristics, and outcomes. Medicine (Baltimore) 2003;82:159-169.
13. Butler J, Schuchat A. Epidemiology of pneumococcal infections in the elderly. Drugs Aging 1999;15 Suppl:S11-S19.
14. Kahn KL, Keeler EB, Sherwood MJ, et al. Comparing outcomes of care before and after implementation of the DRG-based prospective payment system. JAMA 1990;264:1984-1988.
15. Vila-Córcoles A. Advances in pneumococcal vaccines: What are the advantages for the elderly? Drugs Aging 2007;24(10):791-800.
16. Mufson MA, Krause HE, Schiffman G, Hughey DF, et al. Pneumococcal antibody levels one decade after immunization of healthy adults. Am J Med Sci 1987;293:279-284.
17. Fisman DN, Abrutyn E, Spaude KA, et al. Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia. Clin Infect Dis 2006;42:1093-1101. Published Online: March 13, 2006.
18. Melegaro A, Edmunds WJ. The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: A comparison of meta-analyses. Eur J Epidemiol 2004;19:353-363.
19. Domínguez A, Salleras L, Fedson DS, et al. Effectiveness of pneumococcal vaccination for elderly people in Catalonia, Spain: A case-control study. Clin Infect Dis 2005;40:1250-1257. Published Online: March 22, 2005.
20. Sisk JE, Moskowitz AJ, Whang W, et al. Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people [published correction appears in JAMA 2000;283(3):341]. JAMA 1997;278(16):1333-1339.
21. Advisory Committee on Immunization Practices. Recommended adult immunization schedule: United States, October 2007- September 2008. Ann Intern Med 2007;147:725-729. Published Online: October 18, 2007.
22. Lexau CA, Lynfield R, Danila R, et al; Active Bacterial Core Surveillance Team. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 2005;294(16):2043-2051.
23. Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA 2004;292:1333-1340.
24. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003;289:179-186.
25. Nichol KL, Nordin J, Mullooly J, et al. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 2003;348:1322-1332.
26. Reichert TA, Simonsen L, Sharma A, et al. Influenza and the winter increase in mortality in the United States, 1959-1999. Am J Epidemiol 2004;160:492-502.
27. Palache AM, Beyer WE, Sprenger MJ, et al. Antibody response after influenza immunization with various vaccine doses: A double-blind, placebo-controlled, multi-centre, dose-response study in elderly nursing- home residents and young volunteers. Vaccine 1993;11:3-9.
28. Ahmed AE, Nicholson KG, Nguyen-Van-Tam JS. Reduction in mortality associated with influenza vaccine during 1989-90 epidemic. Lancet 1995;346:591-595.
29. Voordouw AC, Sturkenboom MC, Dieleman JP, et al. Annual revaccination against influenza and mortality risk in community-dwelling elderly persons. JAMA 2004;292:2089-2095.
30. Simonsen L, Taylor RJ, Viboud C, et al. Mortality benefits of influenza vaccination in elderly people: An ongoing controversy. Lancet Infect Dis 2007;7:658-666.
31. Jackson ML, Nelson JC, Weiss NS, et al. Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: A populationbased, nested case-control study. Lancet 2008;372:398-405.
32. Jefferson T, Rivetti D, Rivetti A, et al. Efficacy and effectiveness of influenza vaccines in elderly people: A systematic review [published correction appears in Lancet 2006;367(9515):986]. Lancet 2005;366(9492):1165- 1174. Published Online: September 23, 2005.
33. Monto AS, Hornbuckle K, Ohmit SE. Influenza vaccine effectiveness among elderly nursing home residents: A cohort study. Am J Epidemiol 2001;154:155-160.
34. Pascual FB, McGinley EL, Zanardi LR, et al. Tetanus surveillance - United States, 1998-2000. MMWR Surveill Summ 2003;52(3):1-8.
35. Tetanus. http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/tetanus.pdf. Accessed July 23, 2008.
36. Cooper MC. The elderly travellers. Travel Med Infect Dis 2006;4:218-222.
37. Reed CM. Travel recommendations for older adults. Clin Geriatr Med 2007;23(3):687-713, ix.
38. Genton B, D'Acremont V, Furrer HJ, et al. Hepatitis A vaccines and the elderly. Travel Med Infect Dis 2006;4:303-312. Published Online: November 28, 2005.